Naked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in mice
- 1 February 2006
- journal article
- Published by Elsevier in Immunobiology
- Vol. 211 (1-2) , 11-27
- https://doi.org/10.1016/j.imbio.2005.08.002
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response through the Recruitment of Myeloid Suppressor CellsCancer Research, 2004
- Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vectorInternational Journal of Cancer, 2004
- Enzyme Immunoassay for Serum Autoantibody to Survivin and Its Findings in Head-and-Neck Cancer PatientsClinical Chemistry, 2004
- HLA‐B35‐restricted immune responses against survivin in cancer patientsInternational Journal of Cancer, 2003
- Generation of an effective anti‐tumor immunity after immunization with xenogeneic antigensEuropean Journal of Immunology, 2002
- Crystal Structure and Mutagenic Analysis of the Inhibitor-of-Apoptosis Protein SurvivinMolecular Cell, 2000
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999
- Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.The Journal of Experimental Medicine, 1996
- High frequency of altered HLA class I phenotypes in invasive breast carcinomasHuman Immunology, 1996
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993